loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of Certificates of Suitability (CEPs) for r0_cep_2020_025___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 HUBEI HAOSUN PHARMACEUTICAL CO., LTD. Ezhou CN (1)

filter

01 Irinotecan hydrochloride trihydrate (1)

filter

01 China (1)

filter

01 Valid (1)

URL Supplier Web Content
R0-CEP 2020-025 - Rev 00
Valid
Chemical
2022-05-10
2675
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R0-CEP 2020-025 - Rev 00 of Hubei Haosun Pharmaceutical Co., Ltd. Ezhou Cn

Looking for Certificates of Suitability (CEPs) for R0-CEP 2020-025 - Rev 00 of Hubei Haosun Pharmaceutical Co., Ltd. Ezhou Cn 1

20

Hubei Haosun Pharmaceutical Co., Ltd. Ezhou Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their significant offerings is Irinotecan hydrochloride trihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2020-025 - Rev 00

This Chemical Type CEP, issued on May 10, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2675 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY